Javascript must be enabled to continue!
Hyperphosphatemia among end‐stage renal disease patients in developing countries: A forgotten issue?
View through CrossRef
AbstractThe prevalence of hyperphosphatemia and increased calcium–phosphorus product has never been evaluated in a large multicenter study in a developing country. Our aim is to study the prevalence of hyperphosphatemia in 38 HD centers in Egypt (as an example of a developing country) and to correlate it with different co‐morbid conditions and the patient's demographic data. This is a cross‐sectional study conducted on 1005 chronic kidney disease stage 5 patients (CKD‐stage 5) on HD for a period of more than 1 year in 38 dialysis centers in Egypt. All patients were receiving calcium‐based salts as a phosphate binder. Hyperphosphatemia and increased calcium–phosphorus product were evaluated and correlated with different parameters including age, sex, knowledge by diet parameters, HD session duration, the frequency of HD per week, the type of dialysis membrane, the surface area of the dialyzer, dialyzer phosphorus clearance (phosphorus KoA), and the type of dialysate. Other co‐morbid medical conditions and evidence of IHD were also investigated. Hyperphosphatemia was present in 69.1% of cases and a high calcium–phosphorus product was present in 30.2%. A higher calcium–phosphorus product was found among males. 83.2% of those with a poor knowledge by diet parameters had hyperphosphatemia compared with 67.6% in patients with a satisfactory knowledge by diet parameters. 72.3% of patients using a membrane with low‐to‐medium clearance had hyperphosphatemia, compared with 67.2% using a membrane with a high clearance. Seventy‐two percent of patients with IHD were hyperphosphatemic compared with 67.6% of the non‐ischemic patients. Hyperphosphatemia is a major problem in dialysis patients in developing countries, reflecting differences from developed countries regarding dietary habits, ethnic factors, dialysis quality, types of dialysis membranes, as well as economic factors hampering the use of the more expensive phosphate binders. Extended dialysis hours may be a good alternative solution in developing countries.
Title: Hyperphosphatemia among end‐stage renal disease patients in developing countries: A forgotten issue?
Description:
AbstractThe prevalence of hyperphosphatemia and increased calcium–phosphorus product has never been evaluated in a large multicenter study in a developing country.
Our aim is to study the prevalence of hyperphosphatemia in 38 HD centers in Egypt (as an example of a developing country) and to correlate it with different co‐morbid conditions and the patient's demographic data.
This is a cross‐sectional study conducted on 1005 chronic kidney disease stage 5 patients (CKD‐stage 5) on HD for a period of more than 1 year in 38 dialysis centers in Egypt.
All patients were receiving calcium‐based salts as a phosphate binder.
Hyperphosphatemia and increased calcium–phosphorus product were evaluated and correlated with different parameters including age, sex, knowledge by diet parameters, HD session duration, the frequency of HD per week, the type of dialysis membrane, the surface area of the dialyzer, dialyzer phosphorus clearance (phosphorus KoA), and the type of dialysate.
Other co‐morbid medical conditions and evidence of IHD were also investigated.
Hyperphosphatemia was present in 69.
1% of cases and a high calcium–phosphorus product was present in 30.
2%.
A higher calcium–phosphorus product was found among males.
83.
2% of those with a poor knowledge by diet parameters had hyperphosphatemia compared with 67.
6% in patients with a satisfactory knowledge by diet parameters.
72.
3% of patients using a membrane with low‐to‐medium clearance had hyperphosphatemia, compared with 67.
2% using a membrane with a high clearance.
Seventy‐two percent of patients with IHD were hyperphosphatemic compared with 67.
6% of the non‐ischemic patients.
Hyperphosphatemia is a major problem in dialysis patients in developing countries, reflecting differences from developed countries regarding dietary habits, ethnic factors, dialysis quality, types of dialysis membranes, as well as economic factors hampering the use of the more expensive phosphate binders.
Extended dialysis hours may be a good alternative solution in developing countries.
Related Results
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
<b>Frequency of Hyperphosphatemia in Chronic Kidney Disease Patients Admitted to Ayub Teaching Hospital Abbottabad</b>
<b>Frequency of Hyperphosphatemia in Chronic Kidney Disease Patients Admitted to Ayub Teaching Hospital Abbottabad</b>
Background: Hyperphosphatemia is a major biochemical disturbance in chronic kidney disease (CKD) and contributes to accelerated vascular calcification, cardiovascular morbidity, an...
Validation Of Criteria For Renal Response In Patients With Multiple Myeloma (MM) Who Present With Severe Renal Dysfunction
Validation Of Criteria For Renal Response In Patients With Multiple Myeloma (MM) Who Present With Severe Renal Dysfunction
Abstract
Severe renal impairment (RI) in MM patients is a medical emergency. Immediate antimyeloma therapy and appropriate supportive measures are needed because the...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Clinical Evaluation of Niacin in Hemodialysis Patients with Hyperphosphatemia as Adjuvant to Calcium Carbonate
Clinical Evaluation of Niacin in Hemodialysis Patients with Hyperphosphatemia as Adjuvant to Calcium Carbonate
Background: The complications of End Stage Renal Disease ESRD attributed to high morbidity and mortality such as hyperphosphatemia and vascular disease. Vascular smooth muscle cell...
Analisis Tipografi pada Logotype Band Forgotten
Analisis Tipografi pada Logotype Band Forgotten
Abstrak Forgotten merupakan band asal kota Bandung yang beraliran death metal. Band ini telah memiliki beberapa album yang cukup sukses. Salah satu faktor yang turut berperan penti...
Mineral metabolism and outcomes in chronic kidney disease stage 2–4 patients
Mineral metabolism and outcomes in chronic kidney disease stage 2–4 patients
Abstract
Background
Marked hyperphosphatemia, hyperparathyroidism and 25-hydroxyvitamin D deficiency are associated with mortality in dialysis pa...

